https://www.inspiredhygiene.com/feed&follow=1
-
Opinion: Recovery community organizations need more than bake sales to help people survive addiction
Sweeping social change often begins as a ripple in quiet places: conversations around the kitchen table, in church basements, on school campuses,...
-
STAT+: Lander: New cancer plan ‘more ambitious by far’ than original moonshot
WASHINGTON — A more modest cancer moonshot? Not so fast, says Eric Lander. The White House science adviser pushed back on the many...
-
STAT+: How Andreessen Horowitz competes for the best health tech startups
Since Julie Yoo joined Andreessen Horowitz as a general partner in 2019, investment in health care companies has skyrocketed. For entrepreneurs...
-
Listen: Califf’s sudden jeopardy, the quest for a PCSK9 pill, & Covid vaccines for kids
Does President Biden care about the FDA? What can aerobics instructors teach us about genetics? And when can kids get Covid-19 vaccines? We...
-
STAT+: Lawmakers grill key FDA official over controversial Alzheimer’s drug approval
WASHINGTON — The Food and Drug Administration can’t escape questions about Aduhelm. Patrizia Cavazzoni, one of the agency’s...
-
STAT+: PhRMA takes aim at WHO and European Union over support of weakening patent protections
Amid growing concern over access to Covid-19 vaccines and treatments, the U.S. pharmaceutical industry trade group has lashed out at the World...
-
STAT+: Eleven years after buying Genzyme, Sanofi officially ditches subsidiary’s storied name
When the French pharmaceutical giant Sanofi starts moving 2,500 employees from 10 sites in Massachusetts into a pair of new buildings in East...
-
STAT+: Pfizer sues two former employees for stealing trade secrets and creating a rival for diabetes and obesity drugs
Pfizer ( PFE) has accused two former employees of clandestinely creating a pair of companies that are now using stolen trade secrets to...
-
STAT+: With Alzheimer’s drug sales weak, Biogen offers a disappointing financial outlook for 2022
Sales of Aduhelm, Biogen’s treatment for Alzheimer’s disease, continued to underperform expectations in the fourth quarter, Biogen...
-
STAT+: As the telemedicine industry rapidly expands, the Biden administration takes a closer look at who’s benefiting
Telemedicine companies will tell you the pandemic has ushered in a new era of connected health across America. But the Biden administration wants...
-
Apple opens 2022 with a glimpse at its health efforts
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this...
-
‘The numbers are pretty appalling’: Asian scientists rarely awarded top scientific prizes
Some see it as a symptom of a discriminatory “bamboo ceiling” in academia: Despite being heavily represented in American biomedical...
-
STAT+: Pharmalittle: Former Rochester CEO is convicted over opioid crisis; Covid-19 therapies appear cost-effective
Good morning, everyone, and how are you today? We are doing just fine, thank you. Gloomy skies may be hovering over the Pharmalot campus right...
-
STAT+: Such a deal! Covid-19 therapies appear cost-effective … for now
The prices charged for several medicines used to treat people with mild-to-moderate Covid-19 — including pills from Pfizer ( PFE ) and...
-
STAT+: Key lawmaker: ARPA-H won’t be part of NIH
WASHINGTON — A new research agency aimed at developing breakthrough medical technologies won’t be housed within the National...
-
Opinion: Hospitals’ cash prices for services offer a new look at health care pricing
There are several common narratives about variations in health care prices: Uninsured consumers are dunned for full chargemaster prices ,...
-
Opinion: Want to improve trust in U.S. public health agencies? Start with a new mantra
Be first, be right, be credible. That’s the mantra public health leaders follow when it comes to communicating with the public in a...
-
As internet access limits telehealth’s reach, insurers are starting to cover the bill
Billions of dollars have been poured into telehealth during the pandemic: Insurers loosened the purse strings on virtual appointments, digital...
-
STAT+: A scientific pioneer finds herself on the sidelines of the race in xenotransplantation
The last few months have seen a flurry of firsts for the field of xenotransplantation, sparking new hope that the science of making...
-
STAT+: With cancer biomarkers, experts say the future has finally arrived
Back in 2000, when President Clinton called a tie in the race to map the human genome, scientists forecasted a medicinal revolution, one in which...
-
STAT+: Convenience comes at a price: First injectable for HIV prevention isn’t cost-effective, analysis claims
A long-acting injectable to prevent HIV infection may be generating hope that a new era in the battle against AIDS is about to begin. But a newly...
-
Researchers label early CAR-T therapy patient ‘cured’ after living a decade without cancer
In 2010, Doug Olsen became the second person in the world to receive CAR-T cell therapy, an experimental tactic to engineer his own immune cells...
-
STAT Virtual Event: How biomarkers are changing cancer care
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Biomarkers, including genetic alterations in tumor cells...
-
STAT+: Pharmalittle: Gilead to pay $1.25B to settle HIV patent row with Glaxo; Native American tribes strike $590M deal over opioid crisis
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle of the week is already here, which means there is much to do. No...
-
Biden once pledged to ‘cure cancer.’ His new approach is far more modest
WASHINGTON — President Biden has been pledging to “cure” cancer for the past six years, beginning with his moonshot effort as...